Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions

被引:57
作者
Canas, Paula M. [1 ]
Porciuncula, Lisiane O. [1 ]
Simoes, Ana Patricia [1 ]
Augusto, Elisabete [1 ]
Silva, Henrique B. [1 ]
Machado, Nuno J. [1 ]
Goncalves, Nelio [1 ]
Alfaro, Tiago M. [1 ]
Goncalves, Francisco Q. [1 ]
Araujo, Ines M. [1 ]
Real, Joana I. [1 ]
Coelho, Joana E. [2 ]
Andrade, Geanne M. [1 ]
Almeida, Ramiro D. [1 ]
Chen, Jiang-Fan [2 ]
Kofalvi, Attila [1 ]
Agostinho, Paula [1 ,3 ]
Cunha, Rodrigo A. [1 ,3 ]
机构
[1] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal
[2] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[3] Univ Coimbra, Fac Med, P-3004504 Coimbra, Portugal
关键词
adenosine; convulsions; neuroprotection; synapse; synaptotoxicity; synatic plasticity; A(2A) RECEPTOR; KAINIC ACID; INDUCED SEIZURES; HIPPOCAMPAL DAMAGE; KINDLED SEIZURES; A(1); EPILEPSY; ACTIVATION; GLUTAMATE; CAFFEINE;
D O I
10.1523/ENEURO.0385-18.2018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegeneration is a process transversal to neuropsychiatric diseases and the understanding of its mechanisms should allow devising strategies to prevent this irreversible step in brain diseases. Neurodegeneration caused by seizures is a critical step in the aggravation of temporal lobe epilepsy, but its mechanisms remain undetermined. Convulsions trigger an elevation of extracellular adenosine and upregulate adenosine A(2A) receptors (A(2A)R), which have been associated with the control of neurodegenerative diseases. Using the rat and mouse kainate model of temporal lobe epilepsy, we now tested whether A(2A)R control convulsions-induced hippocampal neurodegeneration. The pharmacological or genetic blockade of A(2A)R did not affect kainate-induced convulsions but dampened the subsequent neurotoxicity. This neurotoxicity began with a rapid A(2A)R upregulation within glutamatergic synapses (within 2 h), through local translation of synaptic A(2A)R mRNA. This bolstered A(2A)R-mediated facilitation of glutamate release and of long-term potentiation (LTP) in CA1 synapses (4 h), triggered a subsequent synaptotoxicity, heralded by decreased synaptic plasticity and loss of synaptic markers coupled to calpain activation (12 h), that predated overt neuronal loss (24 h). All modifications were prevented by the deletion of A(2A)R selectively in forebrain neurons. This shows that synaptic A(2A)R critically control synaptic excitotoxicity, which underlies the development of convulsions-induced neurodegeneration.
引用
收藏
页数:12
相关论文
共 61 条
  • [1] Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex
    Alonso-Nanclares, L
    DeFelipe, J
    [J]. NEUROSCIENCE, 2005, 134 (01) : 59 - 68
  • [2] Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus
    Araujo, Ines M.
    Gil, Joana M.
    Carreira, Bruno P.
    Mohapel, Paul
    Petersen, Asa
    Pinheiro, Paulo S.
    Soulet, Denis
    Bahr, Ben A.
    Brundin, Patrik
    Carvalho, Caetana M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2008, 105 (03) : 666 - 676
  • [3] Adenosine A2A receptor and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE)
    Barros-Barbosa, Aurora R.
    Ferreirinha, Fatima
    Oliveira, Angela
    Mendes, Marina
    Graca Lobo, M.
    Santos, Agostinho
    Rangel, Rui
    Pelletier, Julie
    Sevigny, Jean
    Miguel Cordeiro, J.
    Correia-de-Sa, Paulo
    [J]. PURINERGIC SIGNALLING, 2016, 12 (04) : 719 - 734
  • [5] Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures
    Benkovic, SA
    O'Callaghan, JP
    Miller, DB
    [J]. BRAIN RESEARCH, 2004, 1024 (1-2) : 59 - 76
  • [6] Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats
    Berman, RF
    Fredholm, BB
    Aden, U
    O'Connor, WT
    [J]. BRAIN RESEARCH, 2000, 872 (1-2) : 44 - 53
  • [7] Adenosinergic signaling in epilepsy
    Boison, Detlev
    [J]. NEUROPHARMACOLOGY, 2016, 104 : 131 - 139
  • [8] Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease
    Canas, Paula M.
    Patricia Simoes, Ana
    Rodrigues, Ricardo J.
    Cunha, Rodrigo A.
    [J]. NEUROPHARMACOLOGY, 2014, 76 : 51 - 56
  • [9] Adenosine A2A receptors and brain injury:: Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation
    Chen, Jiang-Fan
    Sonsalla, Patricia K.
    Pedata, Felicita
    Melani, Alessia
    Domenici, Maria Rosaria
    Popoli, Patrizia
    Geiger, Jonathan
    Lopes, Luisa V.
    De Mendonca, Alexandre
    [J]. PROGRESS IN NEUROBIOLOGY, 2007, 83 (05) : 310 - 331
  • [10] Caffeine and an adenosine A2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life
    Cognato, Giana P.
    Agostinho, Paula M.
    Hockemeyer, Joerg
    Mueller, Christa E.
    Souza, Diogo O.
    Cunha, Rodrigo A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2010, 112 (02) : 453 - 462